Credit Suisse’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $2.44M | Hold |
|
|||||
|
2023
Q4 | $2.38M | Buy |
|
|||||
|
2023
Q3 | $1.95M | Buy |
|
|||||
|
2023
Q2 | $2.2M | Buy |
|
|||||
|
2023
Q1 | $1.83M | Buy |
|
|||||
|
2022
Q4 | $1.57M | Sell |
|
|||||
|
2022
Q3 | $1.91M | Sell |
|
|||||
|
2022
Q2 | $1.98M | Sell |
|
|||||
|
2022
Q1 | $2.63M | Buy |
|
|||||
|
2021
Q4 | $3.52M | Sell |
|
|||||
|
2021
Q3 | $3.5M | Buy |
|
|||||
|
2021
Q2 | $3.2M | Sell |
|
|||||
|
2021
Q1 | $4.06M | Sell |
|
|||||
|
2020
Q4 | $5.01M | Buy |
|
|||||
|
2020
Q3 | $3.91M | Sell |
|
|||||
|
2020
Q2 | $5.34M | Sell |
|
|||||
|
2020
Q1 | $5.12M | Buy |
|
|||||
|
2019
Q4 | $5.09M | Buy |
|
|||||
|
2019
Q3 | $2.75M | Sell |
|
|||||
|
2019
Q2 | $5.2M | Buy |
|
|||||
|
2019
Q1 | $4.44M | Sell |
|
|||||
|
2018
Q4 | $5.39M | Buy |
|
|||||
|
2018
Q3 | $9.54M | Sell |
|
|||||
|
2018
Q2 | $7.89M | Buy |
|
|||||
|
2018
Q1 | $6.01M | Sell |
|
|||||
|
2017
Q4 | $5.1M | Sell |
|
|||||
|
2017
Q3 | $6.39M | Sell |
|
|||||
|
2017
Q2 | $13.1M | Sell |
|
|||||
|
2017
Q1 | $13.4M | Buy |
|
|||||
|
2016
Q4 | $9.61M | Buy |
|
|||||
|
2016
Q3 | $7.65M | Sell |
|
|||||
|
2016
Q2 | $10.1M | Sell |
|
|||||
|
2016
Q1 | $10.2M | Buy |
|
|||||
|
2015
Q4 | $9.14M | Sell |
|
|||||
|
2015
Q3 | $9.39M | Sell |
|
|||||
|
2015
Q2 | $13.7M | Buy |
|
|||||
|
2015
Q1 | $7.09M | Buy |
|
|||||
|
2014
Q4 | $4.69M | Sell |
|
|||||
|
2014
Q3 | $4.32M | Sell |
|
|||||
|
2014
Q2 | $7.82M | Buy |
|
|||||
|
2014
Q1 | $6.72M | Sell |
|
|||||
|
2013
Q4 | $5.53M | Buy |
|
|||||
|
2013
Q3 | $2.4M | Buy |
|
|||||
|
2013
Q2 | $1.3M | Buy |
|